title: Molecular mechanisms of clinical concentrating and diluting disorders.
abstract: Impaired urinary dilution leading to water retention and hyponatremia may occur in patients with cardiac failure, cirrhosis, pregnancy, hypothyroidism, glucocorticoid and mineralocorticoid deficiency. The mechanisms for these defects predominantly involve the non-osmotic stimulation of arginine vasopressin release with upregulation of aquaporin 2 water channel expression and trafficking to the apical membrane of the principal cells of the collecting duct. These perturbations are reversed by V2 vasopressin receptor antagonists. In contrast, urinary concentration defects leading to polyuria are vasopressin-resistant. They may involve several factors, such as impaired counter-current concentration secondary to downregulation of Na-K-2Cl co-transporter. Vasopressin-resistant downregulation of aquaporin 2 expression has also been described as a factor in impaired urinary concentration.
authors.affiliation: University of Colorado Health Sciences Center, Denver, CO, USA.
authors.forename: Robert W
authors.initials: RW
authors.lastname: Schrier
mesh_terms: D000818:Animals; D065092:Antidiuretic Hormone Receptor Antagonists; D051399:Aquaporin 2 / Q000502:physiology*; D001127:Arginine Vasopressin / Q000378:metabolism*; D001810:Blood Volume / Q000502:physiology; D005260:Female; D006333:Heart Failure / Q000503:physiopathology; D006706:Homeostasis; D006801:Humans; D007010:Hyponatremia / Q000209:etiology / Q000503:physiopathology; D008103:Liver Cirrhosis / Q000503:physiopathology; D008954:Models, Biological; D011141:Polyuria / Q000503:physiopathology; D011247:Pregnancy; D011248:Pregnancy Complications / Q000503:physiopathology; D011311:Pressoreceptors / Q000502:physiology; D028021:Sodium-Potassium-Chloride Symporters / Q000187:drug effects / Q000502:physiology; D014556:Urine / Q000502:physiology*; D014667:Vasopressins / Q000502:physiology; D014882:Water-Electrolyte Balance / Q000502:physiology*
chemical_list: D065092:Antidiuretic Hormone Receptor Antagonists; D051399:Aquaporin 2; D028021:Sodium-Potassium-Chloride Symporters; D014667:Vasopressins; D001127:Arginine Vasopressin